Hydrocortisone Dosing Guidelines for Adrenal Insufficiency and Related Critical Situations

Acute Adrenal Crisis – Adults

• Initial emergency regimen: give 100 mg hydrocortisone IV (or IM) as an immediate bolus, then deliver a continuous IV infusion of 200 mg over 24 h (or 50 mg IV/IM every 6 h) while infusing 1 L isotonic saline during the first hour. [1][2]3
• Fluid therapy: adjust the rate and volume of saline (add 10 % glucose if hypoglycaemic) based on hemodynamic monitoring; continue IV fluids for 24–48 h until the patient is hemodynamically stable. 3
• Transition to oral therapy: when oral intake is possible and the patient is stable, switch to oral hydrocortisone at three times the usual maintenance dose (minimum 60 mg/day) divided TID; maintain this tripled dose for 48 h in uncomplicated cases or up to 1 week if recovery is delayed, then taper gradually to the normal maintenance dose. [3][2]
• Mineralocorticoid re‑introduction: do not restart fludrocortisone until the hydrocortisone dose has been reduced to < 50 mg/day in primary adrenal insufficiency. [3][2]

Acute Adrenal Crisis – Pediatric Patients

• Weight‑based bolus dosing: give 25 mg (≤15 kg), 50 mg (15–25 kg), or 100 mg (>25 kg) hydrocortisone IV or IM plus a 0.9 % saline bolus of 20 mL/kg (repeat up to a total of 60 mL/kg if shock persists). [1][2]
• Repeated dosing: administer 2 mg/kg hydrocortisone every 6–8 h IM/SC or every 6 h by IV infusion. [1][2]
• Glucose and electrolyte support: provide 5 % or 10 % glucose for hypoglycaemia and give NaCl 10–15 mEq/kg/day (max 408 mEq/day). 3
• Maintenance fluids: newborns 150–180 mL/kg/day; older children 2.5–3 L/m²/day. 3
• Oral transition: once oral intake resumes, start 30–50 mg/m²/24 h oral hydrocortisone and taper to the maintenance dose; triple the usual dose for 48 h to 1 week depending on recovery. 3

Septic Shock – Refractory to Fluids & Vasopressors

• Indication: in septic shock unresponsive to fluids and vasopressors > 0.1 µg/kg/min norepinephrine, give hydrocortisone < 400 mg/day for at least 3 days at full dose. 4
• Regimen: 50 mg IV hydrocortisone every 6 h (total 200 mg/day) for ≥ 3 days, extending the course if shock persists. 4
• Evidence: a low‑dose, prolonged regimen is superior to high‑dose, short‑course therapy, reduces 28‑day mortality, and accelerates shock reversal. 4
• Comparative efficacy: hydrocortisone boluses/infusions are more effective than methylprednisolone for shock reversal. 4
• Safety monitoring: watch for hyperglycaemia and hypernatremia; no increased risk of super‑infection or gastrointestinal bleeding at these doses. 4

Peri‑operative Stress Dosing – Adults

• Major surgery: give 100 mg hydrocortisone IV at induction, then continue a continuous IV infusion of 200 mg over 24 h (or 50 mg IV/IM every 6 h) until oral intake resumes; thereafter double the oral dose for 48 h (or up to 1 week if recovery is complicated) and taper to the maintenance regimen. 5
• Minor‑to‑moderate surgery: administer 25–75 mg hydrocortisone per 24 h for 1–2 days, then resume the usual oral dose once recovery is uncomplicated. 5
• Labor & delivery:
  
  • Vaginal delivery: 100 mg IV at onset of labor, followed by 200 mg/24 h continuous infusion (or 100 mg IM then 50 mg IM every 6 h); double the oral dose for 24 h after delivery. 5
  • Cesarean section: 100 mg IV at the start of the procedure, then double the oral dose for 48 h to 1 week. 5

Chronic Maintenance Therapy – Adults

• Primary adrenal insufficiency: 15–25 mg hydrocortisone daily, divided 2–3 doses with the largest dose in the morning. [1][2]
• Secondary adrenal insufficiency: 10–20 mg hydrocortisone daily, divided 2–3 doses with the largest dose in the morning (lower dose because mineralocorticoid function is preserved). [1][2]
• Mineralocorticoid replacement: add fludrocortisone 100 µg/day (range 50–300 µg/day) for primary adrenal insufficiency; monitor blood pressure, plasma renin (target upper‑normal) and electrolytes. Do not use fludrocortisone in secondary adrenal insufficiency. [2][3]

Chronic Maintenance Therapy – Pediatric Patients

• Primary adrenal insufficiency (non‑CAH): 8–15 mg/m²/day hydrocortisone. [1][2]
• Congenital adrenal hyperplasia: 10–18 mg/m²/day hydrocortisone. [1][2]
• Neonates (first month): 20–40 mg/m²/day hydrocortisone. [1][2]
• Secondary adrenal insufficiency: 8–10 mg/m²/day hydrocortisone (lower dose). [1][2]
• Dosing schedule: give 3 doses per day in infants and young children; 2–3 doses in older children. [1][2]
• Growth considerations: doses >15–17 mg/m²/day in adolescents or >20 mg/m²/day in infants may cause growth suppression and reduced adult height. [1][2]
• Mineralocorticoid replacement: fludrocortisone 50–100 µg/day (no BSA adjustment) for primary adrenal insufficiency; add oral sodium chloride 1–2 g/day (≈17–34 mmol) in infants up to 1–2 years of age due to renal mineralocorticoid resistance. 2

Common Pitfalls & Safety Measures

• Do not delay treatment: administer hydrocortisone immediately in suspected adrenal crisis without waiting for laboratory confirmation; rapid clinical improvement is the best diagnostic indicator. [1][2]
• Infusion vs. bolus: continuous IV infusion of 200 mg/24 h is superior for maintaining physiological stress cortisol levels; if unavailable, use 50 mg IV/IM every 6 h. [1][2]
• Fludrocortisone timing: restart fludrocortisone only after hydrocortisone has been tapered below 50 mg/day. [3][2]
• Tapering after high‑dose therapy: after >48–72 h of high‑dose hydrocortisone or >14 days of any glucocorticoid, taper gradually to avoid precipitating adrenal crisis. [1][2]
• Etomidate avoidance: avoid etomidate in patients with known or suspected adrenal insufficiency; if unavoidable, give 100 mg hydrocortisone IV immediately before or after induction. [1][2]

Guideline Recommendations for Management of Adrenal Insufficiency

Chronic Maintenance Therapy

• Hydrocortisone is the preferred glucocorticoid for replacement in adults with adrenal insufficiency because its short half‑life best mimics physiological cortisol rhythms (Endocrine Society) 6.
• In children, glucocorticoid dosing is calculated on body‑surface area (8–15 mg/m²/day divided 2–3 times daily); doses >15–17 mg/m²/day in adolescents or >20 mg/m²/day in infants are associated with growth suppression and reduced adult stature (Endocrine Society) 7.
• Fludrocortisone 100 µg daily is the standard mineralocorticoid replacement dose for children with primary adrenal insufficiency and does not require adjustment for body‑surface area (Endocrine Society) 7.
• Infants (especially the first 6 months) need additional sodium chloride supplementation of 1–2 g/day (≈17–34 mmol) because of mineralocorticoid resistance in immature kidneys (Endocrine Society) 7.
• Under‑replacement of glucocorticoids manifests as poor weight gain, fatigue, anorexia, hyperpigmentation, and salt craving; over‑replacement presents with weight gain, hypertension, and growth suppression in children (Endocrine Society) 7.
• Adequacy of mineralocorticoid therapy is assessed by routine blood pressure measurement, plasma renin activity in the upper‑normal range, and regular electrolyte (sodium, potassium) checks (Endocrine Society) 7.

Acute Adrenal Crisis Management

• Adrenal crisis must be treated immediately without awaiting laboratory confirmation (Endocrine Society) 7.
• Adults: give 100 mg hydrocortisone IV as a bolus, infuse 1 L isotonic saline (0.9 % NaCl) within the first hour, then continue with a continuous IV infusion of 200 mg/24 h (or 50 mg IV every 6 h) (Endocrine Society) 7, 8.
• Children: administer a weight‑based hydrocortisone bolus (≤15 kg → 25 mg; 15–25 kg → 50 mg; > 25 kg → 100 mg) IV or IM, plus 0.9 % NaCl 20 mL/kg (repeat up to a total of 60 mL/kg if shocked) (Endocrine Society) 6, 7.
• If hydrocortisone is unavailable, prednisolone is the preferred alternative; dexamethasone is the least‑preferred option and should be used only when no other glucocorticoid is accessible (Endocrine Society) 7.
• High‑dose hydrocortisone provides sufficient mineralocorticoid activity; therefore, fludrocortisone is not required during the acute phase (Endocrine Society) 6.

Transition to Oral Therapy

• Continue IV hydrocortisone until the patient is hemodynamically stable and can tolerate oral intake; then reduce to 100 mg orally the following day and taper gradually (Endocrine Society) 7.
• In children, start oral hydrocortisone at 30–50 mg/m²/24 h and taper to the maintenance dose (Endocrine Society) 6.
• Resume fludrocortisone 0.05–0.1 mg daily once oral intake is established in patients with primary adrenal insufficiency (Endocrine Society) 6.

Stress‑Dosing (Sick‑Day Rules)

• Fever with bed rest: double the usual oral hydrocortisone dose for a temperature of 38 °C and triple the dose for ≥ 39 °C; maintain the increased dose for 2–3 days until recovery (Endocrine Society) 7, 8.
• Vomiting, diarrhea, or inability to take oral medication: adults receive 100 mg hydrocortisone IM or SC immediately; children receive 50 mg/m² IM (dose stratified by weight) and should seek emergency care (Endocrine Society) 7, 8.
• Major surgery with general anesthesia: give 100 mg IV hydrocortisone at induction, then continue a continuous infusion of 200 mg/24 h (or 50 mg IV every 6 h) throughout the peri‑operative period (Endocrine Society) 7, 8.
• Minor to moderate surgical stress: provide 25–75 mg hydrocortisone per 24 h for 1–2 days; in children, give 50 mg/m² IM or double/triple the usual replacement dose (Endocrine Society) 7.
• Cesarean section: administer 100 mg IV hydrocortisone at the start of the procedure, then double the oral dose for 48 h–1 week (24 h if recovery is rapid) (Endocrine Society) 8.
• Labor and vaginal delivery: give 100 mg IV hydrocortisone at onset of labor, followed by a doubled oral dose for 24 h (Endocrine Society) 8.
• Dental procedures: give an extra 10 mg oral hydrocortisone 1 h before the procedure, then double the oral dose for the next 24 h (Endocrine Society) 8.
• After >48–72 h of high‑dose glucocorticoid therapy or >14 days of exposure, a gradual taper is required to avoid precipitating adrenal crisis (Guideline recommendation) 9.

Patient Education & Emergency Preparedness

• All patients should carry an emergency steroid card (e.g., European steroid emergency card) and an injection kit containing 100 mg hydrocortisone for intramuscular self‑administration (Endocrine Society) 8.
• Patients and families must be educated to recognize adrenal‑crisis signs—hypotension, severe fatigue, nausea/vomiting, altered mental status, hyponatremia, and hypoglycemia—and to administer emergency hydrocortisone promptly (Endocrine Society) 8.

Hydrocortisone Intravenous Therapy in Infants < 1 Year: Evidence‑Based Dosing and Monitoring

Indications & Safety

• Hydrocortisone IV can be safely administered to infants younger than one year when dosing is based on weight or body‑surface‑area for adrenal crisis, primary adrenal insufficiency, or septic shock. [10][11]

Dosing Regimens

Acute Adrenal Crisis

• Initial bolus: 25 mg IV or IM for infants weighing ≤15 kg, given immediately. [10][11]
• Maintenance: 50–100 mg/m² per day, divided q6 h (or given as continuous infusion). [10][11]
• Fluid resuscitation: 0.9 % saline 20 mL/kg; repeat up to a total of 60 mL/kg if shock persists. [10][11]
• Hypoglycemia adjunct: add dextrose 0.5–1 g/kg (or 5–10 mL/kg of D10W). 10

Monitoring Requirements

• Infants require more intensive monitoring than older children because of developmental physiology. 10
• Visit frequency: at least every 3–4 months during the first year of life. 10
• Blood pressure: close monitoring throughout the first year due to increasing mineralocorticoid sensitivity. 10
• Growth parameters: record weight and length at each visit. 10
• Blood glucose: vigilant surveillance for hypoglycemia, which is especially relevant in this age group. 10

Guideline Recommendations

• The Endocrine Society (2016) issues strong recommendations (strength 1QQQE) for hydrocortisone use in pediatric adrenal crisis with age‑appropriate dosing. [10][11]
• The Society’s guidelines explicitly include infants, providing weight‑stratified regimens such as a 25‑mg bolus for infants unable to tolerate oral medication. [10][11]

Practical Clinical Tips

• Do not delay treatment in a suspected adrenal crisis while awaiting laboratory confirmation. [10][11]
• Never use adult fixed doses (e.g., 100 mg) in small infants; always calculate dose based on weight or BSA. [10][11]

Hydrocortisone Tapering and HPA‑Axis Assessment

Indications for Tapering

• The 10 mg daily hydrocortisone dose is below physiologic replacement (15–25 mg/day for adults); therefore, when used as maintenance therapy for adrenal insufficiency it represents the minimum safe dose and should not be tapered further. 12

Cortisol‑Guided Assessment of HPA‑Axis Recovery

• After reducing hydrocortisone to the physiologic replacement range (15–25 mg/day), clinicians should withhold the dose for 24 hours and obtain a morning serum cortisol measurement (8–9 AM) to evaluate hypothalamic‑pituitary‑adrenal (HPA) axis recovery before any further dose reduction. 12
• A morning cortisol < 150 nmol/L (≈5 µg/dL) indicates insufficient HPA recovery; patients should remain on physiologic replacement and have cortisol re‑tested every 1–6 months, without further tapering. 12
• A morning cortisol between 150 and 300 nmol/L (≈5–10 µg/dL) suggests partial recovery; continue physiologic replacement and repeat cortisol testing every few weeks until levels rise above 300 nmol/L. 12
• A morning cortisol > 300 nmol/L (≈10 µg/dL) signifies likely full HPA‑axis recovery, permitting cautious discontinuation of glucocorticoid replacement. 12

Tapering Protocol for Patients on Chronic 10 mg Maintenance

• For patients on chronic 10 mg maintenance therapy who are candidates for cessation (e.g., suspected recovery of secondary adrenal insufficiency), HPA‑axis assessment via a 24‑hour dose hold and morning cortisol measurement is required before stopping therapy. 12
• If the post‑hold morning cortisol exceeds 300 nmol/L, clinicians may safely discontinue hydrocortisone; if it remains < 150 nmol/L, the current dose should be maintained and reassessed in 1–6 months. 12

Safety and Pitfalls

• Fixed taper schedules that do not incorporate cortisol levels or clinical response are discouraged; tapering should be individualized based on serial cortisol measurements and patient symptoms. 12

Immediate Stress‑Dose Hydrocortisone for Patients with Adrenal Insufficiency Experiencing Acute Myocardial Infarction

Definition of Major Stress in Acute MI

• Acute myocardial infarction meets guideline criteria for “severe acute illness requiring hospital admission” and is classified as a major physiological stress that necessitates parenteral stress‑dose glucocorticoids【13】【14】.

Immediate Hydrocortisone Dosing Protocol

• Give 100 mg hydrocortisone IV as a bolus as soon as the MI is diagnosed, followed by continuous IV infusion of 200 mg over 24 h (or 50 mg IV every 6 h if infusion is unavailable)【13】.
• Parenteral administration is mandatory because nausea, vomiting, or hemodynamic instability in acute MI can impair oral absorption【13】【14】.
• Do not withhold stress‑dose steroids in any patient with known adrenal insufficiency during an acute MI; the risk of adrenal crisis outweighs theoretical concerns about steroid effects on myocardial healing【13】.

Duration and Transition of Therapy

• Maintain the full stress‑dose regimen (200 mg/24 h) until the patient is hemodynamically stable and the acute phase of the MI has resolved, which typically requires at least 48–72 hours【13】.
• Once stable and able to take oral medication, switch to oral hydrocortisone at three times the usual maintenance dose (minimum 60 mg/day divided TID) and continue this tripled dose for 48 hours if recovery is uncomplicated, or up to 1 week if complications arise【13】.
• Taper gradually back to the baseline maintenance dose after the high‑dose period; premature tapering can precipitate adrenal crisis【13】.

Contraindications and Pitfalls

• Doubling the maintenance dose is insufficient for major stress; the guideline‑recommended regimen (100 mg bolus + 200 mg/24 h) provides 10–15 times physiological replacement【13】.
• Fludrocortisone is not required during the acute high‑dose hydrocortisone phase because the dose supplies adequate mineralocorticoid activity (no citation needed).

Monitoring During Therapy

• Hemodynamic parameters (blood pressure, heart rate) should be monitored regularly to assess response and guide duration of stress dosing【13】.
• Additional routine monitoring (electrolytes, blood glucose) is advised given the mineralocorticoid and hyperglycemic effects of high‑dose hydrocortisone (general clinical practice, not specifically cited).

Guideline Consensus

• Consensus statements from endocrine guideline bodies affirm that major stress—such as acute MI—requires parenteral stress‑dose glucocorticoids, and that this approach is unequivocally recommended for patients with adrenal insufficiency【13】【14】.

Hydrocortisone Stress‑Dose Management in Severe Pediatric Traumatic Brain Injury

Immediate Emergency Dosing

• Weight‑based bolus: Give 50 mg IV/IM for children weighing 15–25 kg or 100 mg IV/IM for those >25 kg; do not wait for cortisol results because severe TBI with shock is a medical emergency. 15
• Fluid resuscitation: Administer 0.9 % saline 20 mL/kg as a rapid bolus; repeat up to a total of 60 mL/kg if hypotension or ongoing shock persists. 15
• Hypoglycemia correction: If glucose < 70 mg/dL, give dextrose 0.5–1 g/kg (or 5–10 mL/kg D10W for adolescents). 15

Maintenance Hydrocortisone Regimen (Acute Phase)

• Stress‑dose range: 50–100 mg/m² per 24 h (≈ 75–150 mg/day for a 1.5 m² adolescent), delivered either as a continuous IV infusion or divided q6 h. The higher end is preferred for severe TBI with shock physiology. 15
• Guideline endorsement: The Endocrine Society (2016) recommends exactly this dosing for pediatric adrenal crisis. 15

Duration of High‑Dose Therapy & Transition

• Minimum duration: Continue the full stress dose for 48–72 h or until hemodynamic stability is achieved (normotension, lactate clearance, resolution of acidosis). 15
• Switch to oral: When the patient tolerates oral intake and is stable, convert to 30–50 mg/m² per day (≈ 45–75 mg/day) divided TID.
• Tapering: Reduce the oral dose over 48 h to 1 week before moving to a chronic maintenance dose of 8–15 mg/m² per day (≈ 12–23 mg/day) if chronic adrenal insufficiency is diagnosed.

Guideline Recommendations for Related Conditions

• Pediatric septic‑shock guidelines (2009): Recommend hydrocortisone 2–50 mg/kg/day (continuous or divided) for catecholamine‑resistant shock or documented adrenal insufficiency; the same hemodynamic principles apply to shock secondary to severe TBI. [16][17]

Evidence of Adrenal Insufficiency in Severe TBI

• Observational data: Multiple studies show that patients with severe TBI frequently develop absolute or relative adrenal insufficiency; nonsurvivors have lower cortisol levels and higher ACTH‑cortisol ratios. [16][17]

Monitoring & Safety Parameters

• Hemodynamics: Record blood pressure, heart rate, urine output, and lactate every 2–4 h to gauge response to hydrocortisone and fluids. 15
• Intracranial pressure (ICP): Continue ICP monitoring per Brain Trauma Foundation (2019); hydrocortisone does not directly lower ICP but supports cerebral perfusion pressure (CPP). 18
• Blood glucose: Check every 2–4 h; maintain 80–180 mg/dL to avoid hypoglycemia‑related neurologic injury and hyperglycemia‑related infection risk. 19
• Electrolytes: Daily sodium and potassium; watch for hypernatremia after >72 h of high‑dose hydrocortisone due to mineralocorticoid effect. 19

Optional Adrenal Function Testing (If Time Allows)

• Baseline cortisol & ACTH stimulation: A cortisol < 18 µg/dL or a Δ‑cortisol < 9 µg/dL at 60 min indicates adrenal insufficiency and justifies continuation of therapy. [15][16]17
• Do not delay treatment: Clinical diagnosis of adrenal crisis supersedes laboratory confirmation. 15

Common Pitfalls & Mitigation

Pathophysiological Rationale

• Mixed metabolic‑respiratory acidosis in severe TBI signals tissue hypoperfusion and impaired ventilation; hydrocortisone restores vascular tone and catecholamine responsiveness, improving perfusion and lactate clearance. [16][17]
• Cerebral perfusion pressure (CPP): Maintain CPP > 50 mmHg (age‑appropriate target) using fluids, vasopressors, and ICP management; hydrocortisone supports systemic blood pressure but does not directly modify cerebral metabolism. 18

Summary Dosing Table

All dosing recommendations are supported by the Endocrine Society (2016) and the pediatric septic‑shock guideline (2009); the acute stress‑dose regimen is derived from the 2016 clinical endocrinology guideline. [15][16]17